Retatrutide is not approved or available as a licensed treatment, so patients cannot switch from Mounjaro to retatrutide through a regulated UK pharmacy
The choices here fall broadly into four categories: Buy the current duopoly stocks Novo Nordisk and Eli Lilly
States are pulling back coverage largely due to cost: monthly Medicaid spending on Wegovy alone exceeded $192 million in late 2024, and total GLP-1 spending across the program exceeded $3.5 billion in a single year
However, it can be influenced by age and education, and repeated administration can lead to practice-related improvements that complicate the assessment [89]
volume pricing applies at 1,000+ vials
In fact, because youll be eating less, each bite counts more than ever in meeting your nutritional needs [medicalnewstoday.com, medicalnewstoday.com]